Literature DB >> 30179648

Model systems for analysis of dopamine transporter function and regulation.

Moriah J Hovde1, Garret H Larson1, Roxanne A Vaughan1, James D Foster2.   

Abstract

The dopamine transporter (DAT) plays a critical role in dopamine (DA) homeostasis by clearing transmitter from the extraneuronal space after vesicular release. DAT serves as a site of action for a variety of addictive and therapeutic reuptake inhibitors, and transport dysfunction is associated with transmitter imbalances in disorders such as schizophrenia, attention deficit hyperactive disorder, bipolar disorder, and Parkinson disease. In this review, we describe some of the model systems that have been used for in vitro analyses of DAT structure, function and regulation, and discuss a potential relationship between transporter kinetic values and membrane cholesterol.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CFT; Cholesterol; Kinetic parameters; Neuronal cultures; Nucleus accumbens; Striatum

Mesh:

Substances:

Year:  2018        PMID: 30179648      PMCID: PMC6338519          DOI: 10.1016/j.neuint.2018.08.015

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  147 in total

1.  Dopamine transporter synthesis and degradation rate in rat striatum and nucleus accumbens using RTI-76.

Authors:  H L Kimmel; F I Carroll; M J Kuhar
Journal:  Neuropharmacology       Date:  2000-02-14       Impact factor: 5.250

2.  Subcellular fractionation of the brain: preparation of synaptosomes and synaptic vesicles.

Authors:  Gareth J O Evans
Journal:  Cold Spring Harb Protoc       Date:  2015-05-01

3.  Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes.

Authors:  R A Vaughan; R A Huff; G R Uhl; M J Kuhar
Journal:  J Biol Chem       Date:  1997-06-13       Impact factor: 5.157

4.  Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter.

Authors:  C Pifl; O Hornykiewicz; B Giros; M G Caron
Journal:  J Pharmacol Exp Ther       Date:  1996-06       Impact factor: 4.030

Review 5.  Dopaminergic neurons.

Authors:  Shankar J Chinta; Julie K Andersen
Journal:  Int J Biochem Cell Biol       Date:  2004-12-02       Impact factor: 5.085

6.  Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease.

Authors:  Domingo Afonso-Oramas; Ignacio Cruz-Muros; Diego Alvarez de la Rosa; Pedro Abreu; Teresa Giráldez; Javier Castro-Hernández; Josmar Salas-Hernández; José L Lanciego; Manuel Rodríguez; Tomas González-Hernández
Journal:  Neurobiol Dis       Date:  2009-09-17       Impact factor: 5.996

7.  Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport.

Authors:  Narasimha M Midde; Yaxia Yuan; Pamela M Quizon; Wei-Lun Sun; Xiaoqin Huang; Chang-Guo Zhan; Jun Zhu
Journal:  J Neuroimmune Pharmacol       Date:  2015-01-22       Impact factor: 4.147

Review 8.  The SH-SY5Y cell line in Parkinson's disease research: a systematic review.

Authors:  Helena Xicoy; Bé Wieringa; Gerard J M Martens
Journal:  Mol Neurodegener       Date:  2017-01-24       Impact factor: 14.195

9.  β-Hydroxy-β-Methylbutyrate (HMB) Promotes Neurite Outgrowth in Neuro2a Cells.

Authors:  Rafael Salto; Jose D Vílchez; María D Girón; Elena Cabrera; Nefertiti Campos; Manuel Manzano; Ricardo Rueda; Jose M López-Pedrosa
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

10.  PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein.

Authors:  Peter J Hamilton; Andrea N Belovich; George Khelashvili; Christine Saunders; Kevin Erreger; Jonathan A Javitch; Harald H Sitte; Harel Weinstein; Heinrich J G Matthies; Aurelio Galli
Journal:  Nat Chem Biol       Date:  2014-06-01       Impact factor: 15.040

View more
  9 in total

Review 1.  Monoamine transporters: structure, intrinsic dynamics and allosteric regulation.

Authors:  Mary Hongying Cheng; Ivet Bahar
Journal:  Nat Struct Mol Biol       Date:  2019-07-03       Impact factor: 15.369

2.  Dual control of dopamine in Drosophila myeloid-like progenitor cell proliferation and regulation of lymph gland growth.

Authors:  Ankita Kapoor; Achalla Padmavathi; Sukanya Madhwal; Tina Mukherjee
Journal:  EMBO Rep       Date:  2022-04-27       Impact factor: 9.071

3.  The Role of the Dopamine Transporter in the Effects of Amphetamine on Sleep and Sleep Architecture in Drosophila.

Authors:  Caline S Karam; Brenna L Williams; Sandra K Jones; Jonathan A Javitch
Journal:  Neurochem Res       Date:  2021-02-25       Impact factor: 3.996

4.  Dopamine Transporter Genetic Reduction Induces Morpho-Functional Changes in the Enteric Nervous System.

Authors:  Silvia Cerantola; Valentina Caputi; Gabriella Contarini; Maddalena Mereu; Antonella Bertazzo; Annalisa Bosi; Davide Banfi; Dante Mantini; Cristina Giaroni; Maria Cecilia Giron
Journal:  Biomedicines       Date:  2021-04-24

5.  Gut instincts: vitamin D/vitamin D receptor and microbiome in neurodevelopment disorders.

Authors:  Destiny Ogbu; Eric Xia; Jun Sun
Journal:  Open Biol       Date:  2020-07-08       Impact factor: 6.411

6.  A study of the dopamine transporter using the TRACT assay, a novel in vitro tool for solute carrier drug discovery.

Authors:  Hubert J Sijben; Julie J E van den Berg; Jeremy D Broekhuis; Adriaan P IJzerman; Laura H Heitman
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

7.  A microfluidic platform for continuous monitoring of dopamine homeostasis in dopaminergic cells.

Authors:  Yue Yu; Richard P S de Campos; Seolim Hong; Dimitar L Krastev; Siddharth Sadanand; Yen Leung; Aaron R Wheeler
Journal:  Microsyst Nanoeng       Date:  2019-03-11       Impact factor: 7.127

Review 8.  Neuroprotective Polyphenols: A Modulatory Action on Neurotransmitter Pathways.

Authors:  Elzbieta Rebas; Jowita Rzajew; Tomasz Radzik; Ludmila Zylinska
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

9.  The Effect of Lead Exposure on Autism Development.

Authors:  Aanya Goel; Michael Aschner
Journal:  Int J Mol Sci       Date:  2021-02-06       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.